TNPSC Thervupettagam

Hexavalent Vaccine Boost for India

August 9 , 2026 9 hrs 0 min 5 0
  • A study by the Union Health Ministry and global health organisations found that introducing the Hexavalent (six-in-one) vaccine in India’s Universal Immunisation Programme (UIP) could improve vaccination efficiency.
  • The Hexavalent vaccine protects against six diseases — Diphtheria, Tetanus, Pertussis (whooping cough), Hepatitis B, Haemophilus influenzae type b (Hib), and Polio.
  • It can reduce the number of injections required for infants, decrease the workload of health workers, and reduce cold-chain management needs.
  • India vaccinates around 26 million infants annually, and the current system requires multiple vaccine doses during visits.
  • The study found that although the vaccine may have higher initial costs, reducing its price could result in overall savings for the government and households.
  • The vaccine could simplify India’s immunisation programme by replacing the existing Pentavalent vaccine and Fractional Inactivated Polio Vaccine (IPV) doses in future policy decisions.

 

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories